Zobrazeno 1 - 10
of 320
pro vyhledávání: '"D. Felmingham"'
Autor:
M. S. Toleman, E. A. Edwards, D. Felmingham, David H. Lloyd, Stephen J. Baines, Anette Loeffler, S. K. Milsom
Publikováno v:
Journal of Antimicrobial Chemotherapy. 62:1301-1304
Methicillin-resistant Staphylococcus aureus (MRSA) and multiresistant Staphylococcus pseudintermedius (MRSP) have emerged as important pathogens in animal infections. Associated therapeutic problems and the zoonotic potential of staphylococci have re
Autor:
R. J. Leigh, J. D. Felmingham
Publikováno v:
International Journal of Food Science & Technology. 1:345-358
Summary It is well known that the heat transfer properties of air or air-steam mixtures are much inferior to those of steam and that, because of this, entrapped pockets of air in a cannery retort may lead to under-processing and spoilage. Consequentl
Autor:
J.G. Bartlett, A.P. Ball, Lionel A. Mandell, Glenn S. Tillotson, Javier Garau, Ethan Rubinstein, William A. Craig, Keith P. Klugman, Donald E. Low, D. Felmingham, G.L. Drusano
Publikováno v:
Journal of Chemotherapy. 16:419-436
The current document bestows an expert synopsis of key new information presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting in 2003. Data is presented on the socio-political aspects of and policies on
Publikováno v:
Clinical Microbiology and Infection. 10(1):27-36
A pooled analysis of data from 13 phase III studies of telithromycin in the treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute sinusitis or group A β-haemolytic streptococcal pharyngitis and tonsillitis was u
Publikováno v:
Journal of Antimicrobial Chemotherapy. 48:33-42
Community-acquired respiratory tract infections (RTIs) are among the most prevalent infectious diseases in the developed world. They cause considerable morbidity, resulting in a major impact on public health both clinically and socioeconomically. The
Autor:
D. Felmingham
Publikováno v:
Clinical Microbiology and Infection. 7:2-10
Telithromycin, the first of the ketolide antimicrobials, has been specifically designed to provide potent activity against common and atypical/intracellular or cell-associated respiratory pathogens, including those that are resistant to β-lactams an
Autor:
D. Felmingham, J. M. Blondeau
Publikováno v:
Clinical Drug Investigation. 18:57-78
The high prevalence of respiratory tract infections (RTIs) and the increasing resistance of causative pathogens to currently available antibiotics necessitates the development of new, more powerful antimicrobial agents. Such agents must possess a bro
Publikováno v:
Journal of Chemotherapy. 11:5-21
The Alexander Project is an ongoing, multicenter surveillance study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens with testing undertaken in a central laboratory. During the period 1992-1995, is
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 31:563-571
In the European Glycopeptide Susceptibility Survey 7078 Gram-positive isolates collected in 1995 from 70 centers in 9 countries of Western Europe were examined, using a standardized, quantitative susceptibility testing method. Of the 7078 isolates, 6
Autor:
C. Mendes, M. E. Marin, F. Quiñones, J. Sifuentes-Osornio, C. Cuilty Siller, M. Castanheira, C. M. Zoccoli, H. López, A. Súcari, F. Rossi, G. Barriga Angulo, A.J.A. Segura, C. Starling, I. Mimica, D. Felmingham
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 7, Iss 1, Pp 44-61
PROTEKT (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin) is a global surveillance study established in 1999 to monitor antibacterial resistance of respiratory tract organisms. Thirteen centers from Argentina,
Externí odkaz:
https://doaj.org/article/f59c18588e334a6a92b8b3717341e87f